| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.01 | 0.8 |